Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,3 USD | -1,52% | +7,44% | -16,13% |
28/05 | CYTOMX THERAPEUTICS, INC. : via al Buy per Piper Sandler | ZM |
09/05 | CYTOMX THERAPEUTICS, INC. : rating Neutral da BMO Capital | ZM |
Attività
Numero di dipendenti: 121
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Probody Therapeutics
100,0
%
| 53 | 100,0 % | 101 | 100,0 % | +90,38% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 53 | 100,0 % | 101 | 100,0 % | +90,38% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01/12/10 |
Chris Ogden
DFI | Director of Finance/CFO | 40 | 02/08/21 |
Marcia Belvin
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/01/18 |
Yu Waye Chu
CTO | Chief Tech/Sci/R&D Officer | 56 | 17/07/23 |
Lloyd Rowland
CMP | Compliance Officer | 67 | 01/05/18 |
Jeffrey Landau
PRN | Corporate Officer/Principal | 46 | 01/04/21 |
Hong He
PRN | Corporate Officer/Principal | 55 | 01/02/20 |
Danielle Olander
HRO | Human Resources Officer | - | 01/08/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
James Meyers
BRD | Director/Board Member | 59 | 20/12/18 |
Elaine Jones
BRD | Director/Board Member | 69 | 01/12/14 |
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01/12/10 |
Mani Mohindru
BRD | Director/Board Member | 52 | 16/12/20 |
Halley Gilbert
BRD | Director/Board Member | 54 | 27/04/20 |
Matthew Young
BRD | Director/Board Member | 54 | 01/11/15 |
Alan Ashworth
BRD | Director/Board Member | 63 | 29/09/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 77 919 369 | 77 096 182 ( 98,94 %) | 0 | 98,94 % |
Coordinate società
CytomX Therapeutics, Inc.
151 Oyster Point Boulevard Suite 400
94080-1913, South San Francisco
+650 515 3185
http://www.cytomx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-16,13% | 103 Mln | |
+15,58% | 122 Mrd | |
+16,60% | 113 Mrd | |
+17,55% | 26,22 Mrd | |
-24,33% | 19,01 Mrd | |
-19,14% | 15,71 Mrd | |
-17,95% | 15,22 Mrd | |
-46,81% | 14,72 Mrd | |
+58,78% | 14,58 Mrd | |
+4,91% | 13,84 Mrd |
- Borsa valori
- Azioni
- Azione CTMX
- Società CytomX Therapeutics, Inc.